Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyrimidine synthesis is the biochemical pathway responsible for producing pyrimidine nucleotides, essential components of DNA, RNA, and other critical biomolecules. The de novo pathway builds pyrimidines from simple precursors, while the salvage pathway recycles existing pyrimidines. Key enzymes like carbamoyl phosphate synthetase II (CPS II) and OMP decarboxylase are involved, and the pathway is tightly regulated. Dysregulation can lead to disorders like orotic aciduria or impact cancer cell proliferation.
Inhibition of pyrimidine biosynthesis enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyrimidine Synthesis.